Successful Clinical Use of a Plasma-derived, Dual Virus Inactivated Factor VIII Concentrate Incorporating Solvent-detergent and Dry Heat Treatment

M P Smith; K M Rice; G F Savidge

doi:10.1055/s-0038-1655980

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 77(02): 406-407
DOI: 10.1055/s-0038-1655980

Letter to the Editor

Schattauer GmbH Stuttgart

Successful Clinical Use of a Plasma-derived, Dual Virus Inactivated Factor VIII Concentrate Incorporating Solvent-detergent and Dry Heat Treatment

M P Smith

The Haemophilia Centre, Reference Centre for Haemostatic and Thrombotic Disorders, St Thomas’ Hospital, London

,

K M Rice

The Haemophilia Centre, Reference Centre for Haemostatic and Thrombotic Disorders, St Thomas’ Hospital, London

,

G F Savidge

The Haemophilia Centre, Reference Centre for Haemostatic and Thrombotic Disorders, St Thomas’ Hospital, London

› Author Affiliations

Abstract

PDF Download

PDF (155 kb)

References

References
1 Johnson Z, Thornton L, Tobin A, Lawlor E, Power J, Hillary I, Temperley I. An outbreak of hepatitis A among Irish haemophiliacs. International Journal of Epidemiology 1995; 24: 821-828
2 Rosendaal FR, Nieuwenhuis HK, van denBerg HM, Heijboer H, Mauser-Bunschoten EP, van denMeer J, Smith C, Strangers PFW, Briët E. A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in the Netherlands. Blood 1993; 81: 2180-2186
3 Ristol P, Gensana M, Fernandez J, Massot M, Biescas H, Darling A, Jorquera JI, Vericat F. Estudio de validacion de la seguridad viral de un concentrado terapéutico de factor VIII humano de alta pureza, sometido a dos tratamientos especificos de inactivacion viral (FANHDI®). Sangre 1995; 40 (Suppl. 04) 111
4 Scharrer I, Neutzling O. Incidence of inhibitors in haemophiliacs. A review of the literature. Blood Coag Fibrinol 1993; 4: 753-758
5 Azzi A, Ciappi S, Zakvrzewska K, Morfmi M, Mariani G, Mannucci PM. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. American Journal of Hematology 1992; 39: 228-230
6 Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996; 347: 868-869
7 Laurian Y, Dussaix E, Parquet A, Chalvon-Demersay A, d’Oiron R, Tchemia G. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates. Nouvelle Revue Fran9aise d’Hematologie 1994; 36: 449-453